Modulation of STAT3 Signaling With Siltuximab in Type 1 Diabetes
Clinical trial NCT02641522 · COMPLETED
Trial details
- NCT number
- NCT02641522
- Sponsor
- Carla Greenbaum, MD
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-08
- Primary completion
- 2017-03-16
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.